Compass Pathways PLC (CMPS)
7.89
-0.10
(-1.25%)
USD |
NASDAQ |
May 17, 16:00
7.79
-0.10
(-1.27%)
After-Hours: 20:00
Compass Pathways Shareholders Equity (Quarterly): 259.16M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 259.16M |
| December 31, 2023 | 225.74M |
| September 30, 2023 | 253.26M |
| June 30, 2023 | 166.40M |
| March 31, 2023 | 161.64M |
| December 31, 2022 | 181.28M |
| September 30, 2022 | 194.56M |
| June 30, 2022 | 224.58M |
| March 31, 2022 | 259.57M |
| Date | Value |
|---|---|
| December 31, 2021 | 284.41M |
| September 30, 2021 | 305.42M |
| June 30, 2021 | 327.36M |
| March 31, 2021 | 188.50M |
| December 31, 2020 | 196.56M |
| September 30, 2020 | 203.08M |
| June 30, 2020 | -44.86M |
| December 31, 2019 | -30.39M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-44.86M
Minimum
Jun 2020
327.36M
Maximum
Jun 2021
197.43M
Average
203.08M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
| NuCana PLC | 18.96M |
| Autolus Therapeutics PLC | 111.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 308.99M |
| Total Liabilities (Quarterly) | 49.83M |